[Soy protein intake and bone mineral density].

Area of Science:

• Nutritional Science
• Bone Biology
• Endocrinology

Context:

• Osteoporosis is a significant health concern, characterized by reduced bone mineral density (BMD).
• Soy protein contains isoflavones, which are phytoestrogens with potential bone-protective effects.
• Previous studies suggest soy isoflavones influence osteoblast activity and bone metabolism.

Purpose:

• To evaluate the role of soy protein and its isoflavones in preventing bone loss.
• To analyze the association between soy intake, BMD, and bone resorption markers.
• To review existing interventional and clinical trial data on soy's effect on bone health.

Summary:

• In vitro and in vivo studies indicate soy protein and isoflavones stimulate osteoblast activity and protein synthesis, potentially preventing bone loss.
• Observational and some interventional studies show a positive association between soy protein intake and increased BMD, with inhibition of urinary deoxypyridinoline.
• However, a key double-blind, randomized trial did not support the hypothesis that soy protein supplements with isoflavones improve BMD, highlighting the need for further investigation.

Impact:

• Findings underscore the complex role of soy isoflavones in bone metabolism, suggesting potential benefits but also highlighting inconsistencies in clinical evidence.
• This research emphasizes the need for identifying specific, potent isoflavones or optimal delivery methods for effective bone health interventions.
• Further research is crucial to clarify the efficacy of soy-based interventions for osteoporosis prevention and management.